Plain-English translation of NCT07062016 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study for people with aggressive endometrial cancer — a fast-growing form of uterine cancer. Researchers will collect blood and tissue samples from you along with information from your medical records. The goal is to understand the genetic and molecular features of aggressive endometrial cancers so doctors can better predict which patients are at highest risk for the cancer coming back.
Right now, doctors use traditional methods to predict whether endometrial cancer might return, but these methods aren't always accurate. This study is trying to find new genetic and blood-based markers that could help doctors identify high-risk patients earlier and personalize their treatment plans.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will donate a blood sample and allow researchers to use tissue samples from your surgery. Your medical records will be reviewed throughout the study to track your health and cancer outcomes. You will need to be willing to return to Mayo Clinic for follow-up clinical visits as part of the study.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Enrollment target
~100 participants
Started
October 2025
Primary completion
October 2028
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trials Referral Office
Mayo Clinic in Rochester
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.